Showing results (401-410 of 421) with videos related to

Sort By:
Pageof 43
BMC Anesthesiology|March 23, 2018
Experiences of ICU survivors in a low middle income country- a multicenter studyLalitha Pieris, Ponsuge Chathurani Sigera, Ambepitiyawaduge Pubudu De Silva, et al.
Annals of Vascular Surgery|July 1, 1994
Prospective, multicenter study of managing lower extremity venous ulcersT E Arnold, J C Stanley, E P Fellows, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 10, 2015
AMG2850, a potent and selective TRPM8 antagonist, is not effective in rat models of inflammatory mechanical hypersensitivity and neuropathic tactile allodyniaSonya G Lehto, Andy D Weyer, Maosheng Zhang, et al.
Journal of Autoimmunity|January 2, 2017
Environmental factor and inflammation-driven alteration of the total peripheral T-cell compartment in granulomatosis with polyangiitisAnja Kerstein, Silke Schüler, Otávio Cabral-Marques, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2022
Phase II Study of Ponatinib in Advanced Gastrointestinal Stromal Tumors: Efficacy, Safety, and Impact of Liquid Biopsy and Other BiomarkersSuzanne George, Margaret von Mehren, Jonathan A Fletcher, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 21, 2022
Low Concentrations of C5a Complement Receptor Antibodies Are Linked to Disease Activity and Relapse in Antineutrophil Cytoplasmic Autoantibody-Associated VasculitisSebastian Klapa, Antje Müller, Andreas Koch, et al.
Acta Neuropathologica Communications|August 30, 2020
Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathyAllison J Schaser, Teresa L Stackhouse, Leah J Weston, et al.
Cellular and Molecular Life Sciences : CMLS|October 11, 2025
Temporal and protein-specific S-palmitoylation supports synaptic and neural network plasticityAgata Pytyś, Rabia Ijaz, Anna Buszka, et al.
Genome Medicine|October 16, 2014
Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patientsSarah Scollon, Katie Bergstrom, Robin A Kerstein, et al.
The Lancet. Oncology|November 13, 2016
Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trialScott N Gettinger, Lyudmila A Bazhenova, Corey J Langer, et al.
Pageof 43